CA 125 in ovarian cysts, serous effusions and peritoneal washings: immunocytochemical expression

other public-domain-us
View on PubMed

Abstract

The immunocytochemical expression of CA 125 in ovarian cysts, serous effusions and peritoneal washings was examined in patients with primary ovarian malignancies (22) and benign gynecologic conditions (96). The immunostaining of CA 125 was assessed in serous ovarian cysts (CA 125 was detected in 3 out of 14 serous ovarian cysts), follicular ovarian cysts (0/5), luteinized cysts (3/3), endometriotic cysts (6/11), serous cystoadenomas (4/4) and mucinous cystoadenomas (0/2). Reactive mesothelial cells (6/6) showed a low but homogeneous staining which was never found in negative peritoneal washings (0/47). Neoplastic cells in positive peritoneal washings were highly positive (20/22), except for 2 mucinous cystoadenocarcinomas. The reactivity of OC 125 with endometrial and reactive mesothelial cells shows the importance of employing a combination of MoAbs to improve conventional morphologic diagnosis.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Antigens, Neoplasm Biomarkers, Tumor CA-125 Antigen Ovarian Cysts Ovarian Neoplasms Antigens, Neoplasm Ascitic Fluid Ascitic Fluid Biomarkers, Tumor CA-125 Antigen Cystadenocarcinoma, Mucinous Cystadenocarcinoma, Mucinous Cystadenoma, Mucinous Cystadenoma, Mucinous Cystadenoma, Serous Cystadenoma, Serous Endometriosis Endometriosis Female Humans

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-06-20T06:14:18.781669+00:00
pubmed
last seen: 2026-05-13T22:11:18.900538+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine